Navigation Links
New Compound May Fight HIV
Date:4/30/2009

Study in mice finds added benefit from cholesterol-reducing agent ,,

THURSDAY, April 30 (HealthDay News) -- Drugs that stimulate cells to release cholesterol might prove effective in fighting the HIV virus, which causes AIDS, a new study suggests.

George Washington University researchers tested a compound called TO-901317 in mice and found that the treatment restored cholesterol outflow from HIV-infected scavenger cells (macrophages) and white blood cells (lymphocytes). Release of cholesterol from these cells had been greatly inhibited by HIV.

The study also found that the compound "potently suppressed HIV-1 in both cell types," and this anti-HIV effect led to significant reductions of HIV levels in the mice.

The findings were to be presented Thursday at the American Heart Association's conference in Washington, D.C., on arteriosclerosis, thrombosis and vascular biology.

People with HIV face an increased risk of atherosclerosis, which leads to coronary artery disease and heart attack, according to background information in a news release from the Heart Association. The researchers said that the findings suggest a new approach to reducing infectivity and lowering cholesterol levels in people with HIV.

Drugs such as TO-901317 "may provide a double benefit to HIV-infected patients by reducing HIV replication and preventing the development of atherosclerosis with HIV infection," they said.

More information

The U.S. National Institute of Allergy and Infectious Diseases has more about HIV treatment.



-- Robert Preidt



SOURCE: American Heart Association, news release, April 30, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Coloring Compound in Fruits, Veggies May Cut Colon Cancer Risk
2. Sugary Sodas High in Diabetes-Linked Compound
3. Red wine compound shown to prevent prostate cancer
4. CutisPharma Selected by Medicine Shoppe International as Preferred Vendor for Unit-of-Use Compounding Kits
5. A Chinese medicine compound has satisfactory anti-cancer effects on hepatocellular carcinoma
6. VioQuest to Present Data on Oncology Compounds VQD-002 and Lenocta(TM) at AACR-NCI-EORTC International Meeting
7. Organon Signs an Exclusive, Worldwide Licence Agreement on Advanced Antithrombotic Compounds With Endotis Pharma
8. Primus Innovations and Health Robotics Launch Strategic Partnership to Accelerate Transformation in Chemotherapy Compounding
9. Cannabis Compound May Stop Metastatic Breast Cancer
10. Prostate Cancer Treatments Often Compound Existing Health Problems
11. Pharmacopeia and GlaxoSmithKline Collaboration Identifies Two Additional Lead Compounds
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Compound May Fight HIV
(Date:9/19/2017)... (PRWEB) , ... September 19, 2017 , ... The ISO ... to help businesses and organizations become more efficient and improve customer satisfaction. ISO 9001:2015 ... into their own QMS, with a deadline of September 2018. , As ...
(Date:9/19/2017)... ... 2017 , ... Bone Solutions Inc. (BSI), an orthobiologics technology ... device, OsteoCrete®. OsteoCrete® bone void filler is designed to assist with bone repair ... critical property for bone health and development. , “We’re excited to bring this ...
(Date:9/19/2017)... ... September 19, 2017 , ... First Choice Emergency Room , ... Howard Ng, as the new Medical Director of its Pflugerville- FM 685 facility. ... Director of our Pflugerville- FM 685 location,” said Dr. Stephen Van Roekel, Reginal Medical ...
(Date:9/19/2017)... (PRWEB) , ... September 19, 2017 , ... ... across the country with the Davidson Fellows Scholarship on September 27 at a ... projects in Science, Technology, Engineering, Mathematics, Literature and Music. , “I am honored ...
(Date:9/19/2017)... ... 19, 2017 , ... MarkeTouch Media has partnered with fred’s ... a modern design with a more streamlined user experience and is designed to ... app includes hundreds of digital coupons that can be clipped to a customer’s ...
Breaking Medicine News(10 mins):
(Date:9/12/2017)... NEW YORK , Sept. 12, 2017   EcoVadis ... global supply chains, has published the first annual edition of its Global ... more than 20,400 companies evaluated by EcoVadis, based on Scorecard Ratings that ... ... Risk & Performance Index ...
(Date:9/9/2017)... 2017  Eli Lilly and Company (NYSE: ... data for lasmiditan, an investigational, oral, first-in-class molecule for ... improvements compared to placebo in the Phase 3 SPARTAN ... 18th Congress of the International Headache Society (IHC) in ... presented today demonstrate lasmiditan,s potential to reduce pain and ...
(Date:9/7/2017)... Ind. , Sept. 7, 2017  Zimmer Biomet ... in musculoskeletal healthcare, today announced that it will be ... Global Healthcare Conference at the Grand Hyatt hotel in ... 11, 2017 at 11:40 a.m. Eastern Time. ... via Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com ...
Breaking Medicine Technology: